Uncategorized
VIDEO: Aura hopes to bring first ocular melanoma treatment to fruition
NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Elisabet de los Pinos, PhD, CEO of Aura Biosciences, discusses the work the company is doing to bring its treatment for ocular melanoma using viral nanoparticle conjugates to the U.S.